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Abstract 
Apoptosis is now recognized as one of the major processes regulating the size of cell populations. However, despite intensive 
investigations the biochemical and enzymological mechanisms involved in apoptosis remain unclear. In the present study we demonstrate 
activation of a CaZ+/Mg2+-dependent donuclease during VP-16-induced apoptosis in MCF7 cells. Nuclease activation occurred prior 
to the appearance of internucleosomal DNA fragmentation, suggesting that this activation may be an early and possibly critical step in 
drug-induced apoptosis. Analy:ds of the internucleosomal DNA fragments showed that they contained phosphorylated Y-ends, indicating 
that they were produced by a Ca2+/Mg2+-dependent endonuclease. 
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1. Introduction 
Apoptosis was first described by Kerr and co-workers 
as a form of cell death that is characterized by a series of 
morphological changes and internucleosomal DNA degra- 
dation (DNA laddering) [1,2]. Since internucleosomal DNA 
degradation was generally considered a hallmark of apop- 
tosis, it was assumed that a nuclear endonuclease had to be 
activated for apoptosis to occur [2-4]. Of the many differ- 
ent endonuclease activities identified, a Ca2+/Mg2+-de - 
pendent endonuclease was considered the most likely can- 
didate for the 'apoptotic' nuclease, since several studies 
have found that internucleosomal DNA fragmentation of
chromatin occurred during in vitro incubation of isolated 
cell nuclei in the presence of both Ca 2÷ and Mg 2÷ ions 
[4-7]. Evidence that a similar nuclease activity may also 
be responsible for internucleosomal DNA degradation i  
vivo came from studies which suggested that increased 
Abbreviations: VP-16, etoposide; 5-FdUrd, 5-fluoro-2'-deoxyuridine; 
DAPI, 4',6-diamino-2-phenylindole; CLAP,calf intestinal kaline phos- 
phatase; SDS, sodium dodecyl sulfate; PBS, phosphate buffer solution; 
TE buffer, 10 mM Tris-HCl/1 m2d EDTA (pH 8.0); TAE buffer, 40 mM 
Tris-acetate/2 mM EDTA (pH 7.8). 
* Corresponding author. E-mail:: eschneid@pop.nih.gov. Fax: + 1 (301) 
4020172. 
0167-4889/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSDI 0167-4889(94)00233-9 
intracellular calcium levels were sufficient o activate DNA 
degradation during apoptosis [8-11]. Subsequent studies 
have identified an endonuclease activity(ies) that was Ca 2 +- 
and/or MgZ+-dependent and was able to cleave chromatin 
into oligonucleosomal DNA fragments in vitro [12-15]. 
However, alternate nucleases have also been proposed as 
candidates for DNA degradation during apoptosis [16-19]. 
Recent advances in the understanding of the molecular 
mechanisms of apoptosis uggested that the typical DNA 
degradation into oligonucleosomal fragments (DNA lad- 
dering) may only be the endproduct of a cascade of 
stepwise DNA degradations. There is now evidence to 
suggest that chromatin degradation during apoptosis Occurs 
in distinct steps: an initial cleavage into high molecular 
weight fragments of approx. 300 kbp, followed by a 
further degradation into approx. 50 kbp fragments and 
finally into the typical oligonucleosomal ladder [20-23]. 
Whether these distinct cleavage steps are mediated by one 
or several nucleases is not known. Furthermore, whether 
nuclease activation must precede the onset of apoptosis, or 
whether it is the result of the induction of apoptosis is 
unclear. 
Many, if not all, tissues rely on the balance between cell 
proliferation and cell death to maintain homeostasis. The 
loss of this balance is thought o be responsible for neo- 
plastic growth. While traditionally studies of tumor biol- 
ogy have concentrated on an increased rate of cell prolifer- 
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ation as the cause for the increase in tissue mass, more 
recently the concept was proposed in which a reduction in 
the rate of natural cell death leads to a subsequent increase 
in tumor mass. Furthermore, studies have demonstrated 
that many anticancer drugs such as etoposide, methotrex- 
ate, cisplatin, chlorambucil and 5-FdUrd can induce apop- 
tosis in tumor cells in vivo and in vitro [24-26]. 
Despite intensive research, the exact biochemical path- 
ways to and the molecules involved in apoptosis remain 
elusive. The widespread appearance of internucleosomal 
DNA degradation during apoptosis uggests that an en- 
donuclease may be critically involved in this process. In 
the present study we present evidence indicating that acti- 
vation of a Ca2+/Mg2+-dependent donuclease was in- 
volved in VP-16-induced apoptosis in human mammary 
carcinoma MCF7 cells and that this activation preceded 
the appearance of internucleosomal DNA degradation. Re- 
sults from this study have been presented in abstract form 
at the 94th annual meeting of the American Association 
for Cancer Research, 1994. 
2. Materials and methods 
from the culture supernatant by centrifugation and com- 
bined with cells that had remained attached to the culture 
dish and were harvested by scraping. The combined cells 
were washed in PBS and counted with a Coulter Counter. 
Cells were stored as a pellet at -20°C until further 
analysis. 
2.4. Isolation of cell nuclei 
Isolation of cell nuclei was performed essentially as 
previously described [15]. Briefly, 10 7 cells were sus- 
pended in 800 /xl ice-cold buffer containing 50 mM 
Tris-HC1 (pH 8.0), 5 mM CaC12, 0.1% Triton X-100, 0.9 
M sucrose and homogenized with 5-7 strokes of a motor- 
ized glass/teflon homogenizer. The homogenate was over- 
laid onto a sucrose cushion containing 50 mM Tris-HC1 
(pH 8.0), 5 mM CaC12, 1.2 M sucrose at a ratio of 2 vols. 
of homogenate o 1 vol. of sucrose cushion. Samples were 
centrifuged for 30 min at 750 × g at 4 ° C in a swinging- 
bucket rotor. The pellet, containing the cell nuclei, was 
resuspended in 200 /xl buffer containing 50 mM Tris-HC1 
(pH 8.0), 5 mM CaCI z, 0.25 M sucrose, 50% glycerol and 
stored at - 20 ° C. 
2.1. Materials 2.5. Nuclear extract 
DMEM medium, antibiotics solution, fetal bovine 
serum, pBR322, calf intestinal alkaline phosphatase (CLAP) 
and T4 polynucleotide kinase were purchased from 
Gibco/BRL (Gaithersburg, MD). [T-32p]ATP was pur- 
chased from New England Nuclear (Wilmington, DE), and 
RNase A and proteinase K were obtained from 
Boehringer-Mannheim (Indianapolis, IN). DAPI was ob- 
tained from Sigma (St. Louis, MO). VP-16 was kindly 
donated by Dr. B.K. Sinha, National Cancer Institute 
(Bethesda, MD). 
2.2. Cell culture 
MCF7 human breast cancer cells were maintained at 
37°C in 5% CO 2 in DMEM medium supplemented with 
10% fetal bovine serum, streptomycin (100 /zg/ml) and 
penicillin (100 U/ml).  
2.3. VP-16 treatment 
MCF7 cells were plated into 135-mm culture dishes at a 
concentration of 10 6 cells per dish and maintained for 3-4 
days, after which time they were in logarithmic growth 
phase. At the beginning of the experiment (day 0) the 
medium was replaced and 50 /xM VP-16 (experimental 
cells) or 0.05% DMSO (control cells) were added. Day 0 
cells were harvested irectly after medium replacement. 
During the next 8 days experimental (drug-treated) and 
control (DMSO only-treated) cells were collected daily 
To prepare nuclear extracts an aliquot of cell nuclei was 
pelleted and resuspended in 10 mM Tris-HC1 (pH 8.0) at a 
DNA concentration of 5 mg/ml.  Three volumes of extrac- 
tion buffer (10 mM Tris-HCl (pH 8.0), 0.4 M KC1, 0.1% 
Triton X-100) were then added to the suspension of cell 
nuclei and nuclear proteins were extracted for 60 min at 
+ 4 ° C, followed by centrifugation at 24000 X g for 30 
min. The supernatant was used as nuclear extract and 
stored at - 20 ° C. 
2.6. Detection of endonuclease activity 
To detect endonuclease activity, 0.5 /zg of supercoiled 
plasmid pBR322 DNA were digested with nuclear extract 
containing 0.5 /xg or 1 /zg of protein in 30 ~1 incubation 
buffer (10 mM Tris-HCl, l0 mM MgCI2, l mM CaCI 2) 
for 30 min at 37 ° C. These concentrations of MgC12 and 
CaC12 had been previously found to give maximal endonu- 
clease activity [15]. After 30 min proteinase K and SDS 
were added to a concentration of 0.1 mg/ml  and 1%, 
respectively, and incubation was continued for 30 min at 
37 ° C. The DNA was then extracted with phenol/chloro- 
form/isoamyl alcohol (50:49:1) and analyzed by elec- 
trophoresis on a 1% agarose gel containing 2 /xg/ml of 
ethidium bromide in Tris-acetate-EDTA buffer (TAE). The 
gel was photographed under UV-light using Polaroid type 
57 (positive) or 55 (negative) film. Negatives were scanned 
on a densitometer and nuclease activity was quantitated as 
the amount of linear DNA produced. 
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Fig. 1. Fluorescence microscopy ofDAPI stained MCF7 cells before (A) and after (B and C) 8 days of VP-16 treatment. Cells were stained with DAPI as 
described in Section 2. 
2.7. DNA laddering analysis 
2 • 106 cells were lysed in 500/x l  of lysis buffer (5 mM 
Tris-HCl (pH 7.4), 20 mM EDTA, 0.5% Triton X-100) on 
ice for 2 h, followed by centrifugation at 30 000 X g for 30 
min. The supernatants were treated with RNase A (0.5 
mg/ml )  for 60 min at 50 ° C, followed by proteinase K
(0.4 mg/ml )  in the presence of 1% SDS for another 60 
min at 50 ° C, ext racted twice with pheno l /  
chloroform/isoamyl alcohol, and precipitated with ethanol. 
The DNA was dissolved in 10 mM Tris-HCl (pH 8.0), 1 
mM EDTA (TE). 2 /xg of DNA were loaded onto a 1.8% 
agarose gel and electrophoresed in TAE buffer for 2 h at 
100 V. 
2.8. Analysis of DNA ends 
To dephosphorylate the 5'-ends of cleaved DNA, 5 ~g 
DNA was incubated in calf intestinal alkaline phosphatase 
buffer in the presence of 5 units of ClAP at 37 ° C for 1 h. 
The reaction was stopped by heating to 75°C for 10 min 
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Fig. 2. Analysis of DNA fragmentation in MCF7 cells treated with 50 p.M VP-16 for 8 days. Cells were harvested daily and DNA was isolated as 
described in Section 2 and separated on a 1.8% agarose gel. M: A/Hind III DNA fragments a  molecular weight markers. 
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and the DNA was purified by extraction with 
phenol/chloroform/isoamyl alcohol and precipitation with 
ethanol. 1 /zg of this DNA was then end-labeled by 
incubation in 20 /xl reaction buffer (60 mM Tris-HC1 (pH 
7.8), 10 mM MgC1 z, 0.33 /zM ATP, 15 mM 2-mercapto- 
ethanol) with 5 units of T4 polynucleotide kinase in the 
presence of 100 /xCi of [y-32p]ATP at 37 ° C for 2 h. The 
reaction was stopped by adding 1 /xl of 0.5 M EDTA. The 
labeled DNA was separated from unincorporated nu- 
cleotides by filtration on Miniprep Spun Columns (Phar- 
macia P-L Biochemicals) in accordance with the manufac- 
turer's instructions. 0.2-0.3 /zg of the end-labeled DNA 
were then used for analysis by agarose gel electrophoresis, 
followed by autoradiography. 
2.9. DAP1 staining of MCF 7 cells 
Approx .  10 6 cells were trypsinized, washed once in 
PBS and fixed in 70% ethanol. Fixed cells were cen- 
trifuged, resuspended in 2 ml pepsin (0.5%) and incubated 
for 10 min at room temperature. Then 2 ml DAPI (5 
/xg/ml) and 0.2 ml RNase (1 mg/ml) were added and 
incubated for 20 min. Cells were examined by fluores- 
cence microscopy. 
2.10. Protein measurements 
Protein concentrations were measured by the method of 
Bradford [27]. 
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Fig. 3. Characterization f the endonuclease activity in nuclear extracts 
from MCF7 cells. Nuclear extract (1 /xg of protein) from MCF7 cells 
treated with VP-16 for 8 days was incubated with 0.5 /.~g of plasmid 
pBR322 DNA in reaction buffer containing 10 mM Tris-HC1 (pH 8.0) 
and different divalent cations: lane 1: plasmid DNA only incubated in 
buffer containing 10 mM Tris-HCl (pH 8.0), 10 inM MgC12, 1 mM 
CaC12, but no nuclear extract; lane 2 :10  mM MgC12; lane 3 :1  mM 
CaC12; lane 4:10 mM MgC12 andl mM CaCI2; lane 5: the same as in 
lane 4, but also with 5 mM EDTA and 5 mM EGTA. After incubation for 
30 min, the samples were treated as described in Section 2, and the DNA 
was separated on a 1% agarose gel in TAE buffer in the presence of 2 
/xg/ml ethidium bromide. SC, L, R: supercoiled, linear and relaxed 
forms of plasmid DNA, respectively. 
3. Results 
3.1. Effect of VP-16 on MCF7 cells 
DAPI staining and fluorescence microscopy were used 
to assess whether drug-induced cytotoxicity in MCF7 cells 
was accompanied by morphological changes associated 
with apoptosis. As shown in Fig. 1, untreated MCF7 cells 
displayed uniformly stained nuclei (Fig. 1A). In contrast, 
following 8 days exposure to VP-16, MCF7 cells exhibited 
the classical morphological features of apoptosis uch as 
chromatin margination at the nuclear periphery (Fig. 1B) 
and blebbing of the cell nucleus (Fig. 1C). 
3.2. DNA fragmentation i MCF7 cells after VP-16 treat- 
ment 
Since MCF7 cells that had been exposed to VP-16 
displayed morphological features typically associated with 
apoptosis, we next examined the effect of VP-16 treatment 
on internucleosomal DNA fragmentation. DNA laddering 
became apparent after 4 days of drug treatment and gradu- 
ally increased uring further drug exposure (Fig. 2). In 
contrast, DNA laddering was not observed in untreated 
control cells until day 7, when some DNA degradation i to 
longer oligonucleosome fragments was observed. This may 
represent some cell death due to nutrient depletion during 
the 7 days in culture. A semiquantitative analysis of DNA 
fragmentation after 8 days revealed that approx. 6-times 
more control cells than VP-16-treated cells were required 
to give the same amount of fragmented DNA. Thus, VP-16 
exposure resulted in significantly greater DNA fragmenta- 
tion that occurred earlier than in control cells. 
3,3. Endonuclease activity in MCF7 cells 
Preliminary experiments revealed the presence of en- 
donuclease activity in nuclear extracts from VP-16-treated 
MCF7 cells. In order to characterize this activity, we 
examined the effect of different divalent cations on nucle- 
ase activity. As shown in Fig. 3, nuclease activity in 
nuclear extracts from VP-16-treated MCF7 cells was read- 
ily detected in the presence of 10 mM MgC12 (lane 2). 
Incubation with 1 mM CaCI 2 (lane 3) also produced some 
nuclease activity, but maximal activity was observed in the 
presence of both cations (lane 4). In contrast, incubation in 
the presence of EGTA and EDTA abolished this activity 
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(lane 5). This indicated that the nuclease activity in MCF7 
cells was Ca2+/Mg2+-dependent. 
In order to determine whether drug-induced apoptosis 
and DNA laddering were associated with increased en- 
donuclease activity, nuclear extracts from MCF7 cells 
treated with VP-16 for different lengths of time were 
assayed for endonuclease activity. As shown in Fig. 4B, 
low levels of nuclease activity were present in control 
untreated MCF7 cells (compare lanes C with lanes 0). 
However, when MCF7 cells were treated with VP-16, an 
approx. 3-fold increase in endonuclease activity was ob- 
served after 2 days of drug treatment (Fig. 4A), when more 
than 90% of the cells still excluded Trypan blue and 
remained attached to the ctdture dish. This activity contin- 
ued to increase up to approx. 10-fold over control levels 
after 8 days of VP-16 treatment (Fig. 4C). In contrast, no 
increase of nuclease activity over basal levels was found in 
MCF7 cells that were maintained in the absence of VP-16. 
Thus, the drug-induced apoptosis in MCF7 cells was ac- 
companied by an increase in endonuclease activity which 
preceded the appearance of internucleosomal DNA frag- 
mentation (compare Fig. 2 with Fig. 4). 
3.4. Characterization of the endonuclease cleavage prod- 
ucts 
The products of endonuclease cleavage are character- 
istic for the type of endonuclease catalyzing the reaction. 
Ca2÷/Mg2÷-dependent endonuclease produces DNA frag- 
ments with 5'-P and 3'-OH ends, whereas acid endonucle- 
ases produce DNA fragments with 5'-OH and 3'-P ends 
[28]. To confirm that the VP-16-induced DNA fragmenta- 
tion in MCF7 cells was indeed mediated by a 
Ca2+/Mg2+-dependent donuclease and not by an acid 
endonuclease, as suggested by some studies [17,29], the 
5'-ends of the DNA fragments formed in MCF7 cells 
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Fig. 4. Endonuclease activity in nuclear extracts from MCF7 ceils treated with (A) or without (B) 50/zM VP-16. Nuclear extracts (1 /zg of protein) were 
incubated with 0.5 /~g of plasmid pBR322 DNA in incubation buffer (10 mM Tris-HC1 [pH 8.0], 10 mM MgCI2, 1 mM CaC12) for 30 min. After 
incubation, the samples were treated as described in Section 2 and the DNA was separated on a 1% agarose gel in TAE buffer in the presence of 2 /xg/ml 
ethidium bromide. SC, L, R: supercoiled, linear and relaxed forms of plasmid DNA, respectively. (C) Densitometric quantitation of the amount of linear 
DNA in the gels shown in (A) and (B); (0 )  nuclear extract from control cells, (A)  nuclear extract from experimental cells. The gels shown were 
photographed and the negatives scanned on a densitometer. Nuclease activity was measured as the amount of linear DNA. 
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during VP-16 treatment were examined. DNA isolated 
from MCF7 cells at day 0 and after 8 days with or without 
VP-16 was treated with T4 kinase in vitro in the presence 
of [y-32p]ATP. As shown in Fig. 5B, only the DNA 
isolated from cells after 8 days in culture became labeled. 
Furthermore, labeling was only detected after dephospho- 
rylation of the 5'-ends with alkaline phosphatase, indicat- 
ing that the 5'-ends were originally phosphorylated. This 
result was consistent with the assumption that intracellular 
DNA degradation during apoptosis was due to a 
cae+/Mg2+-dependent endonuclease. Although some la- 
beling was also detected in DNA isolated from untreated 
cells after 8 days, at least 5-fold larger amounts of DNA 
had to be loaded onto the gel in order for the labeling to 
become detectable (Fig. 5) and only fragments with higher 
molecular weight were labeled. In addition, phosphatase- 
dependent 5'-end labeling of higher molecular weight frag- 
ments from VP-16-treated cells was detected as early as 
day 2, when enzymatic activity started to increase (data not 
shown). These results further confirmed that VP-16 treat- 
ment of MCF7 cells induced DNA fragmentation much 
more extensive than occurred through nutrient depletion 
alone. 
To determine that the Ca2+/Mg2+-dependent donu- 
clease detected in nuclear extracts from MCF7 cells by our 
in vitro assay was of the same type as the one that 
produced DNA fragmentation i  whole cells, we digested 
plasmid pBR322 DNA in vitro with extracts of cell nuclei 
prepared after 2 and 8 days of VP-16 treatment under two 
different reaction conditions: (1) neutral condition (10 mM 
Tris-HC1, pH 8.0) in the presence of 10 mM MgCI 2 and 1 
mM CaC12 (our standard condition) or (2) acid condition 
(50 mM Na-acetate, pH 5.4) without divalent cations. The 
digested plasmid DNA was then treated with T4 kinase 
with or without prior alkaline phosphatase treatment. The 
results of this experiment are shown in Fig. 6. Under the 
condition favoring Ca2+/Mg2+-dependent donuclease 
activity, the cleaved plasmid DNA was labeled only after 
prior alkaline phosphatase treatment, confirming that the 
enzyme present in nuclear extracts cleaved DNA with 5'-P 
and 3'-OH ends. In contrast, DNA digested under the acid 
condition was equally labeled with and without prior alka- 
line phosphatase treatment. Therefore, we concluded that 
the endonuclease responsible for DNA degradation in 
MCF7 cells is a Ca2+/Mg2+-dependent endonuclease. 
4. D iscuss ion  
It is now widely assumed that apoptosis is responsible 
for anticancer drug-induced cell death. However, relatively 
little is known about the exact mechanisms that lead to 
drug-induced apoptosis. The prominence of internucleoso- 
mal DNA degradation has led to the hypothesis that a 
nuclear endonuclease was required for apoptosis to occur 
and that its activation was an early and essential step and 
required de novo protein synthesis. The enzyme most 
commonly regarded as the apoptotic endonuclease is a 
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Fig. 5.5'  end labeling of cellular DNA cleaved in vivo. (A) cellular DNA was isolated as described in Section 2 for DNA laddering analysis, then 5'-end 
labeled with T4 kinase with or without prior alkaline phosphatase treatment. 0.1 /~g and 0.5 ~g labeled DNA from VP-16-treated and control cells, 
respectively, was separated on a 1.8% agarose gel in TAE buffer, stained with ethidium bromide and photographed. (B) autoradiogram of the gel shown in 
A. M: end-labeled A/Hind IlI DNA fragments. 
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Ca 2+/Mg2 +-dependent endonuclease [12,13,30-32], al- 
though a number of other enzymes has recently also been 
suggested to play a role in apoptosis [16-18,33]. 
Few studies have directly compared DNA degradation 
and endonuclease activity. Activation of a Ca z +/Mg 2 +-de- 
pendent endonuclease during apoptosis was shown in rat 
prostate cells in vivo after castration [9] and in nutrient-de- 
pleted murine myeloma cells [32]. In the present study we 
demonstrate hat a Ca2+/Mg2+-dependent donuclease 
activity increased markedly after VP-16 treatment of hu- 
man mammary tumor MCF7 cells in vitro. Using specific 
end-labeling of the cleavage products, we have further 
confirmed that this endonuclease activity was a 
Ca2+/Mg2+-dependent endonuclease. In addition, the in- 
crease in nuclease activity preceded the appearance of 
internucleosomal DNA fragmentation by 2-3 days. Thus, 
one could speculate that cytotoxic drug treatment stimu- 
lated a Ca2+/Mg2+-dependent endonuclease activity, ei- 
ther directly or indirectly, which then in turn promotes 
and/or accelerates cell death via apoptosis. The mecha- 
nism(s) of endonuclease activation remain unclear. Isaacs 
and co-workers have proposed that activation occurs via a 
rapid calcium ion influx into the injured cells [9]. How- 
ever, other mechanisms such as changes in phosphoryla- 
tion of the endonuclease or some putative regulatory pro- 
tein have been suggested by studies howing that apoptosis 
could be prevented by inhibitors of phosphatases [34,35]. 
It has recently been suggested that an early and possibly 
critical event in apoptosis was the cleavage of chromatin 
into 300 kbp fragments followed by further cleavage into 
50 kbp fragments [21,23]. The enzyme involved in this 
initial fragmentation has not been identified. Our observa- 
tion that the increase in Ca2+/Mg2+-dependent endonu- 
clease activity preceded the appearance of the small 
oligonucleosomal fragments in VP-16-treated MCF7 cells 
suggested a possible role for the Ca2+/MgZ+-dependent 
endonuclease in the early steps of drug-induced apoptosis. 
However, Brown et al. [22] recently suggested that the 
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Fig. 6. 5' end labeling of plasmid pBR322 DNA cleaved in vitro by nuclear extract from VP-16-treated cells under neutral or acid conditions. (A) 0.5 /xg 
of plasmid pBR322 DNA was incubated with 1 /xg of nuclear extract protein from MCF7 cells treated with 50 /xM VP-16 for 2 or 8 days under two 
different conditions: (1) neutral condition, containing 10 mM Tris-HCl (pH 8.0), 10 mM MgC12, 1 mM CaCI2, or (2) acid condition, containing 50 mM 
Na-acetate (pH 5.4). After incubation the samples were treated with proteinase K, extracted with phenol/chloroform/isoamyl alcohol and the DNA was 
precipitated with ethanol. The DNA of each sample was 5'-end labeled with or without prior alkaline phosphatase treatment and then separated on a 1% 
agarose gel in TAE buffer. (B) autoradiogram of the gel shown in (A). M: end-labeled A/Hind III DNA fragments. 
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enzyme involved in the earliest stages of high molecular 
weight DNA degradation had characteristics that differed 
from those of the Ca2+/Mg2+-dependent donuclease. 
Further progress on this question awaits the identification 
and isolation of the nuclease(s) involved. 
Our study furthermore demonstrated that human breast 
cancer MCF7 cells could undergo apoptosis following 
treatment with VP-16 in vitro. MCF7 cells stained with the 
DNA chromophor DAPI after 8 days of VP-16 treatment 
showed the classical morphological features of apoptosis, 
i.e., margination of chromatin at the nuclear periphery, 
chromatin condensation and fragmentation f the cell nu- 
cleus. In addition we also found clear internucleosomal 
DNA fragmentation (DNA laddering) which is widely 
regarded as a hallmark of apoptosis. In contrast, a recent 
study by Oberhammer et al. [23] failed to detect any 
evidence for apoptosis in MCF7 cells that were serum-de- 
pleted for 2 h. While it is difficult to compare the two 
results because of the different experimental conditions 
used, it is conceivable that the mechanism(s) of cell death 
induced by VP-16 is different from that induced by starva- 
tion. Further experiments are needed to resolve this dis- 
crepancy. 
Taken together, our experiments indicated that the en- 
zyme activity induced by VP-16 treatment and presumably 
responsible for the internucleosomal DNA fragmentation is 
a neutral Ca2+/Mg2+-dependent zyme. We have fur- 
thermore shown that stimulation of a Ca2+/Mg2+-depen - 
dent endonuclease activity preceded the appearance of 
small oligonucleosomal DNA fragments, suggesting that 
activation of this enzyme may be an early and possibly 
critical step in drug-induced apoptosis. In addition, we 
have demonstrated that VP-16 treatment of human mam- 
mary MCF7 cells in culture led to cell death by apoptosis. 
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